Sustainability of Forestomach Hyperplasia in Rats Treated with Ethyl Acrylate for 13 Weeks and Regression after Cessation of Dosing

Abstract

In a chronic study conducted by the National Toxicology Program (NTP), gavage administration of 100 or 200 mg ethyl acrylate (EA)/kg/day, 5 days/week, to F344 rats and B6C3F1 mice resulted in a significant dose-dependent increase in the incidence of squamous cell papillomas and carcinomas of the forestomach of both sexes of rats and mice. No increase in the incidence of tumors was observed at any other site in these rats. Chemically-induced cell proliferation is currently thought to play a role in the development and progression of chemically-induced neoplasia. Therefore, a stop-study was initiated where 100 or 200 mg EA/kg (in com oil) was administered daily, 5 days/week, for 13 weeks. Rats sacrificed at the end of the treatment regimen had severe epithelial hyperplasia of the forestomach. No lesions were observed in the glandular stomach or liver of EA-treated rats. Forestomach hyperplasia induced by EA included upward and downward cell proliferation. However, forestomachs of rats treated for 13 weeks and sacrificed 8 weeks after the last EA dose exhibited a significant decline in the incidence and severity of forestomach mucosal hyperplasia. Histopathologic evaluation of forestomachs of EA-treated rats (13 weeks) which were allowed a 19-month-recovery (with no exposure to EA) showed further decline in the incidence and severity of mucosal cell hyperplasia. These results indicate that gavage administration of EA to rats results in extensive and sustained forestomach mucosal hyperplasia. The sustainability of forestomach hyperplasia is apparently dependent on the continued exposure of rats to ethyl acrylate, and regressed after cessation of dosing. Furthermore, although enough post-treatment time was allowed for tumors to develop after cessation of EA administration, forestomachs exhibited a nearly complete recovery with no increased incidence of papillomas or carcinomas. It, therefore, remains to be determined what duration of exposure or other factors are critical for reversibility or progression of EA-induced forestomach mucosal hyperplasia to neoplasia.

Keywords

Toxicology F344 male rats ethyl acrylate forestomach toxicity forestomach hyperplasia sustainability reversibility forestomach cell proliferation carcinogenesis

References

1. Ashby J , Richardson CR , and Tinwell H (1989). Inactivity of ethyl acrylate in the mouse bone marrow micronucleus assay. Mutagenesis 4: 283–285.

2. Balmain A , Ramsden M , Bowden G , and Smith J (1984). Activation of Harvey-ras gene in chemically induced benign skin papillomas. Nature 307: 658–660.

3. Cohen SM and Ellwein LB (1990). Cell proliferation and carcinogenesis. Science 249: 1007–1011.

4. Cohen SM , Ellwein LB , and Johansson SL (1987). Bladder tumor promotion. In: Nongenotoxic Mechanisms of Carcinogenesis [Banbury Report 25], BE Butterworth and TJ Slaga (eds). Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, pp. 25–29.

5. DeBethizy JD , Udinskey JR , Scribner HE , and Frederick CB (1987). The disposition of acrylic acid and ethyl acrylate in male Sprague-Dawley rats. Fund. Appl. Toxicol. 8: 549–561.

6. DePass LR , Fowler EH , Meckley DR , and Weil CS (1984). Dermal oncogenicity bioassays of acrylic acid, ethyl acrylate, and butyl acrylate. J. Toxicol. Environ. Health 14: 115–120.

7. Farber E and Sarma DSR (1987). Hepatocarcinogene-sis: A dynamic cellular perspective. Lab. Invest. 56: 4–22.

8. Fredrick CB , Hazelton GA , and Frantz JD (1990). The histopathological and biochemical response of the stomach of male F344/N rats following two weeks of oral dosing with ethyl acrylate. Toxicol. Pathol. 18: 247–256.

9. Ghanayem BI , Burka LT , and Matthews HB (1987). Ethyl acrylate distribution, macromolecular binding, excretion, and metabolism in male Fischer 344 rats. Fund. Appl. Toxicol. 9: 389–397.

10.

10. Ghanayem BI , Maronpot RR , and Matthews HB (1986). Association of chemically induced cell proliferation and carcinogenesis. Cancer Letts. 32: 271–278.

11.

11. Ghanayem BI , Burnett VL , Matthews HB , and Cunningham ML (1990). Ethyl acrylate-induced cell proliferation in target and nontarget organs: Correlation with carcinogenicity. Proc. Am. Assoc. Cancer Res. 31: 138.

12.

12. Ghanayem BI , Maronpot RR , and Matthews HB (1985). Ethyl acrylate induced gastric toxicity: I. Effect of single and repetitive dosing. Toxicol. Appl. Pharmacol. 80: 323–335.

13.

13. Ghanayem BI , Maronpot RR , and Matthews HB (1985). Ethyl acrylate induced gastric toxicity: II. Structure-toxicity relationships and mechanism. Toxicol. Appl. Pharmacol. 80: 336–344.

14.

14. Ghanayem BI , Maronpot RR , and Matthews HB (1986). Ethyl acrylate induced gastric toxicity: III. Development and recovery of lesions. Toxicol. Appl. Pharmacol. 83: 576–583.

15.

15. Hirose M , Inoue T , Asamoto M , Tagawa Y , and Ito N (1986). Comparison of the effects of 13 phenolic compounds in induction of proliferative lesions of the forestomach and increase in the labeling indices of the glandular stomach and urinary bladder epithelium of Syrian golden hamsters. Carcinogenesis 7: 1285–1289.

16.

16. IARC (1986). Some chemicals used in plastics and elastomers. IARC Monog. Ecal. Carcinog. Risk Chem. Humans 39: 67–112.

17.

17. Iverson, F , Lok E , Rena E , Karpinski K , and Clayson DB (1985). A 13 week feeding study of butylated hydroxyanisole: the subsequent regression of the induced lesions in male Fischer F344 rat forestomach epithelium. Toxicology 35: 1–11.

18.

18. Loury DJ , Goldsworthy TL , and Butterworth BE (1987). The value of measuring cell replication as a predictive index of tissue-specific carcinogenic potential. In: Nongenotoxic Mechanisms of Carcinogenesis [Banbury Report 25], BE Butterworth and TJ Slaga (eds). Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, pp. 119–134.

19.

19. Marsman DS , Cattley RC , Conway JG , and Popp JA (1988). Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepa-tocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xyli-dino)-2-pyrimidinylthioacetic acid (W-14,643) in rats. Cancer Res. 48: 6739–6744.

20.

20. Masui T , Asamoto M , Hirose M , Fukushima S , and Ito N (1986). Disappearance of upward proliferation and persistence of downward basal cell proliferation in rat forestomach papillomas induced by butylated. hydroxyanisole. Jpn. J. Cancer Res. (Gann) 77: 854–857.

21.

21. Miller RR , Young JT , Kociba RJ , Keyes DG , Bonder KM , Calhoun LL , and Ayres JA (1985). Chronic toxicity and oncogenicity bioassay of inhaled ethyl acrylate in Fischer 344 rats and B6C3F1 mice. Drug Chem. Toxicol. 8 (1&2): 1–42.

22.

22. Monticello MT , Morgan KT , Everitt JI , and Popp JA (1989). Effects of formaldehyde gas on the respiratory tract of Rhesus monkeys: Pathology and cell proliferation. Am. J. Pathol. 134: 515–527.

23.

23. Nera EA , Iverson F , Lok E , Armstrong CL , Karpinski K , and Clayson DB (1988). A carcinogenesis reversibility study of the effects of butylated hydroxyanisole on the forestomach and urinary bladder in male Fischer 344 rats. Toxicology 53: 251–268.

24.

24. NTP (National Toxicology Program) (1986). Carcinogenesis bioassay of ethyl acrylate. Technical report series #259, Publication (NIH) 82–2515. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Environmental Health Sciences, Research Triangle Park, NC.

25.

25. Pitot HC (1986). Fundamentals of Oncology, 3rd ed. Marcel Dekker, Inc., New York, 532 pp.

26.

26. Przybojewska B , Dziubaltowska E , and Kowalski Z (1984). Genotoxic effects of ethyl acrylate and methyl acrylate in the mouse evaluated by the micronucleus test. Mutat. Res. 135: 189–191.

27.

27. Reynolds SH , Stowers SJ , Patterson RM , Maronpot RR , Aaronson SA , and Anderson MW (1987). Activated oncogenes in B6C3F1 mouse liver tumors: Implications for risk assessment. Science 11: 1309–1316.

28.

28. Short BG , Burnett VL , and Swenberg JA (1989). Elevated proliferation of proximal tubule cells and localization of accumulated α-2u-globulin in F344 rats during chronic exposure to unleaded gasoline or 2,2,4-trimethylpentane. Toxicol. Appl. Pharmacol. 101: 414–431.

29.

29. Solt DB , Cayama E , Sarma DSR , and Farber E (1980). Persistence of resistant putative preneoplastic hepa-tocytes induced by N-nitrosodiethylamine or N-methyl-N-nitrosourea. Cancer Res. 40: 1112–1118.

30.

30. Swenberg JA , Fedtke N , Fennel TR , and Walker VE (1990). Relationships between carcinogen exposure, DNA adducts and carcinogenesis. In: Progress in Predictive Toxicology, DB Clayson , IC Munro , P Shubic , and JA Swenberg (eds). Elsevier Science Publishers, Amsterdam, pp. 161–184.

31.

31. Sukumar S , Notario V , Martin-Zanca D , and Bar-bacid M (1983). Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutation. Nature 306: 658–661.

32.

32. US Department of Health and Human Services, Public Health Service, National Institutes of Health (1985). Guide for the Care and Use of Láboratory Animals. NIH Publication No. 86–23, National Institutes of Health, Bethesda, MD, pp. 1–83.

33.

33. Waegemakers THJM and Bensik MPM (1984). Non-mutagenicity of 27 aliphatic acrylate esters in Sal-monella-microsome test. Mutat. Res. 137: 95–102.

34.

34. Weisman R , Stowers SJ , Miller E , Anderson M , and Miller J (1986). Activating mutations of the c-Ha-ras protooncogene in chemically induced hepatomas of the male B6C3F1 mouse. Proc. Natl. Acad. Sci. 83: 5285–5289.

35.

35. You M , Candrian U , Maronpot RR , Stoner GD , and Anderson MW (1989). Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse. Proc. Natl. Acad. Sci. 86: 3070–3074.